Results 81 to 90 of about 36,896 (275)

Long-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucoma [PDF]

open access: yes, 2014
The aim of the study was to evaluate the long-term 24-hour intraocular pressure (IOP) efficacy of travoprost monotherapy in primary open-angle glaucoma ...
Biagioli, Elena   +6 more
core   +1 more source

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy

open access: yesArthritis &Rheumatology, EarlyView.
Objective Treatment of childhood chronic idiopathic uveitis (cCIU) is predominantly based on studies in juvenile idiopathic arthritis–associated uveitis and expert opinion. Our aim was to report the treatment outcomes of our cohort of cCIU. Methods Retrospective multicenter study involving the rheumatology and ophthalmology units at Florence, Italy ...
Ilaria Maccora   +5 more
wiley   +1 more source

The trabecular bypass stent in a pseudophakic glaucoma patient: A 1-year follow-up

open access: yesClinical Ophthalmology, 2008
Antonio M Fea, Monica Dogliani, Federica Machetta, Gabriella Lale-Lacroix, Beatrice Brogliatti, Federico MGrignoloIstituto di Fisiopatologia Clinica, Clinica Oculistica, Università di Torino, ItalyPurpose: To describe the 1-year success of a ...
Antonio M Fea   +5 more
doaj  

Where does selective laser trabeculoplasty stand now? A review [PDF]

open access: yes, 2016
Background: Chronic treatment of glaucoma can present a challenge in patients who lack the means and/or the discipline to use daily glaucoma medication. We wondered if selective laser trabeculoplasty (SLT) could be a useful alternative.
De Belder, Maya   +3 more
core   +2 more sources

Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure [PDF]

open access: yesHuman Molecular Genetics, 2007
Glaucoma is a leading cause of worldwide irreversible visual impairment and blindness and is a clinically and genetically heterogenous group of optic neuropathies. Specific mutations in the myocilin (MYOC) gene cause primary open angle glaucoma (POAG) with varying age-of-onset and degree of severity.
Allan R, Shepard   +8 more
openaire   +2 more sources

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova   +5 more
wiley   +1 more source

Long-term efficacy and safety of ab externo canaloplasty in the Polish Caucasian population with open-angle glaucoma: A 3-year retrospective study.

open access: yesPLoS ONE
This study aimed to assess the effectiveness and safety of ab externo canaloplasty over a 3-year follow-up period in Polish Caucasian patients with glaucoma.
Joanna Konopińska   +2 more
doaj   +1 more source

The Role of Low-frequency TRANS-orbital Magnetic Stimulation in Normalization of Intraocular Pressure in Patients with Primary Open-angle Glaucoma

open access: yesOftalʹmologiâ, 2016
Purpose. Assessment of the effectiveness of low-frequency magnetic therapy on the dynamics of intraocular pressure in the treatment of primary and uncompensated medical means of open-angle glaucoma. Patients and Methods.
I. A. Makarov, Yu. I. Voronkov
doaj   +1 more source

Image database system for glaucoma diagnosis support [PDF]

open access: yes, 2008
Tato práce popisuje přehled standardních a pokročilých metod používaných k diagnose glaukomu v ranném stádiu. Na základě teoretických poznatků je implementován internetově orientovaný informační systém pro oční lékaře, který má tři hlavní cíle.
Peter, Roman
core  

24-h Efficacy of Glaucoma Treatment Options [PDF]

open access: yes, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt.   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy